KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Change in Acquisitions & Divestments (2018 - 2025)

Moderna (MRNA) has disclosed Change in Acquisitions & Divestments for 8 consecutive years, with -$2.3 billion as the latest value for Q4 2025.

  • On a quarterly basis, Change in Acquisitions & Divestments fell 234.95% to -$2.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.4 billion, a 40.69% decrease, with the full-year FY2025 number at $2.4 billion, down 40.69% from a year prior.
  • Change in Acquisitions & Divestments was -$2.3 billion for Q4 2025 at Moderna, down from $1.2 billion in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $2.7 billion in Q2 2025 to a low of -$2.3 billion in Q4 2025.
  • A 5-year average of $907.6 million and a median of $896.5 million in 2022 define the central range for Change in Acquisitions & Divestments.
  • Peak YoY movement for Change in Acquisitions & Divestments: surged 1368.75% in 2023, then plummeted 234.95% in 2025.
  • Moderna's Change in Acquisitions & Divestments stood at $2.0 billion in 2021, then plummeted by 54.24% to $929.0 million in 2022, then dropped by 7.0% to $864.0 million in 2023, then tumbled by 178.82% to -$681.0 million in 2024, then tumbled by 234.95% to -$2.3 billion in 2025.
  • Per Business Quant, the three most recent readings for MRNA's Change in Acquisitions & Divestments are -$2.3 billion (Q4 2025), $1.2 billion (Q3 2025), and $2.7 billion (Q2 2025).